chr1-246987457-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_020394.5(ZNF695):c.1058G>A(p.Arg353Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000472 in 1,610,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_020394.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF695 | NM_020394.5 | c.1058G>A | p.Arg353Gln | missense_variant | 4/4 | ENST00000339986.8 | NP_065127.5 | |
ZNF695 | NM_001204221.2 | c.390+668G>A | intron_variant | NP_001191150.2 | ||||
ZNF695 | NR_037892.2 | n.543+664G>A | intron_variant | |||||
ZNF670-ZNF695 | NR_037894.2 | n.573+664G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF695 | ENST00000339986.8 | c.1058G>A | p.Arg353Gln | missense_variant | 4/4 | 1 | NM_020394.5 | ENSP00000341236.7 | ||
ZNF670-ZNF695 | ENST00000465049.6 | n.358+664G>A | intron_variant | 5 | ENSP00000428213.1 |
Frequencies
GnomAD3 genomes AF: 0.0000463 AC: 7AN: 151074Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000487 AC: 12AN: 246180Hom.: 0 AF XY: 0.0000674 AC XY: 9AN XY: 133612
GnomAD4 exome AF: 0.0000473 AC: 69AN: 1458840Hom.: 0 Cov.: 37 AF XY: 0.0000634 AC XY: 46AN XY: 725668
GnomAD4 genome AF: 0.0000463 AC: 7AN: 151190Hom.: 0 Cov.: 33 AF XY: 0.0000406 AC XY: 3AN XY: 73854
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at